The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: A systematic review and meta-analysis.
 
Daniel Araujo
Honoraria - AstraZeneca; Libbs; MSD; Novartis; Tersera
Consulting or Advisory Role - MSD Oncology
 
Bruno Lins de Souza
No Relationships to Disclose
 
Mariana Fauth Seibel
No Relationships to Disclose
 
Aline Fares
Honoraria - AstraZeneca; Bristol-Myers Squibb/Pfizer; Janssen Oncology
Consulting or Advisory Role - AstraZeneca
 
Vitor Liutti
No Relationships to Disclose